Spatial characterization of the BT-20 triple negative breast cancer spheroidal model

Show simple item record

dc.contributor.advisor Cordier, Werner
dc.contributor.coadvisor Steenkamp, Vanessa
dc.contributor.coadvisor Cromarty, Allan Duncan
dc.contributor.coadvisor Van den Bout, Jan Iman
dc.contributor.postgraduate Ncube, Keith Ntokozo
dc.date.accessioned 2019-07-04T12:14:45Z
dc.date.available 2019-07-04T12:14:45Z
dc.date.created 2019-09
dc.date.issued 2019
dc.description Dissertation (MSc)--University of Pretoria, 2019. en_ZA
dc.description.abstract Breast cancer is a commonly diagnosed cancer in women, with increasing diagnosis and mortality rates. The triple-negative sub-type of the disease is characterised by lack of hormone-receptor overexpression, exhibition of poorly characterised molecular aberrations, and treatment failure. Chemotherapy is the current mainstay; however, it fails to slow tumor progression, and this is partially attributed to the lack of characterisation of biological features that drive treatment failure. There is, therefore, a need to characterise the biological features of triple-negative breast cancer, in order to develop effective therapies against the disease. Researchers widely use monolayer cell culture in pre-clinical screening of anticancer drugs. However, the development of effective anti-cancer drugs is hampered by limitations inherent to these culture systems, as they insufficiently mimic the physiological characteristics of tumours in vivo. Spheroids have been suggested as a bridge to the gap between monolayers and animal models, as they combine the flexibility and cost-effectiveness of cell culture with the spatial and molecular attributes of tissue. This study aimed to grow and characterise a spheroid model of triple-negative breast cancer with regards to growth, morphology, and drug sensitivity. The hanging drop and liquid overlay techniques were compared to select a method for growing spheroids. Spheroid growth was assessed using phase contrast microscopy and the bicinchoninic acid assay. Viability was assessed using the fluorescein diacetate (FDA)/propidium iodide (PI) assay. Haematoxylin and eosin staining were used for morphological evaluation. An iridium complex was used to investigate the induction of hypoxia. The sulphorodamine B and acid phosphatase assays, FDA/PI staining and phase contrast microscopy were used to assess the 72-h cytotoxicity effects of doxorubicin in monolayers and spheroids. Immunostaining and optical clearing were used to visualise the spatial distribution of the Ki-67 antigen and cadherins in spheroids. en_ZA
dc.description.availability Unrestricted en_ZA
dc.description.degree MSc en_ZA
dc.description.department Pharmacology en_ZA
dc.description.sponsorship National Research Foundation en_ZA
dc.description.sponsorship University of Pretoria en_ZA
dc.identifier.citation Ncube, KN 2019, Spatial characterization of the BT-20 triple negative breast cancer spheroidal model, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/70368> en_ZA
dc.identifier.other S2019 en_ZA
dc.identifier.uri http://hdl.handle.net/2263/70368
dc.language.iso en en_ZA
dc.publisher University of Pretoria
dc.rights © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
dc.subject UCTD en_ZA
dc.title Spatial characterization of the BT-20 triple negative breast cancer spheroidal model en_ZA
dc.type Dissertation en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record